BridgeMD
New treatment option for Nasolabial Folds, Wrinkles
Official title A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds
ClinicalTrials.gov ID: NCT07467239
What this study is testing
- What it's testing
- This is a prospective, randomized, controlled clinical investigation designed to evaluate the performance and safety of DMFI300 for the treatment of nasolabial folds. 30 adult participants will receive treatment with the investigational device and the comparator device using a split-face design.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Men and women aged 18-70 years.
- Score of 3 to 4 on the Wrinkle Severity Rating Scale (WSRS) for both nasolabial folds.
- Willing and able to provide written informed consent.
- Willing to comply with study procedures and follow-up visits.
- Willing to refrain from other facial cosmetic procedures affecting the nasolabial folds during the study.
You likely can't join if
- Use of antiplatelet agents, vitamin E, or NSAIDs within 2 weeks before screening or planned use within 2 weeks after treatment.
- History or presence of bleeding disorders.
- Participation in another clinical investigation within 1 month prior to screening.
- Pregnant or breastfeeding women, or women planning pregnancy during the study.
- Women of childbearing potential not using an effective method of contraception.
The study team makes the final eligibility decision.
Where it's taking place
- Marbella, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marbella, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.